Digital Pathology Podcast

Send us Fan Mail
Where is AI in pathology actually becoming useful right now? In this episode of DigiPath Digest, I review 4 new PubMed papers across digital pathology, whole slide imaging (WSI), computational pathology, medical education, forensic pathology, and breast cancer AI. We look at a deep learning tool for coronary artery stenosis measurement in forensic autopsies, an AI-powered digital pathology model for renal pathology education, an open-source quality control tool for prostate biopsy whole slide images, and a breast cancer stage prediction model built for resource-constrained settings using low-magnification H&E slides. I also share updates on the upcoming second edition of Digital Pathology 101 and the decision to make AI paper summaries public on the podcast feed to help busy pathology professionals stay current. 
Highlights
 
[01:28] Update on the upcoming second edition of Digital Pathology 101 and the release of public AI paper summaries for faster literature review.

[05:22] Paper 1: Deep learning for coronary artery stenosis evaluation in forensic autopsies using whole slide imaging. Why objective stenosis measurement matters, how the model outperformed visual estimates, and why this could affect adoption in forensic pathology.

[15:18] Paper 2: AI-powered digital pathology with case-based teaching in renal education. A practical discussion on annotated digital slides, flipped classroom learning, and how digital pathology can improve pathology education and diagnostic reasoning.

[21:34] Paper 3: Open-source AI for quantitative quality control in prostate biopsy whole slide images. Why WSI quality control matters, what PathProfiler measures, and how automated QC can support remote pathology workflows.

[32:38] Paper 4: Breast cancer stage prediction from H&E whole slide images in resource-constrained settings. A look at low-magnification AI, vision transformers, and what moderate performance can still mean when access to advanced testing is limited.

[45:06] Closing thoughts, invitation to vote for future AI paper summaries, and a final reminder to download Digital Pathology 101. 
Resources
Paper 1: Development of a deep learning-based tool for coronary artery stenosis evaluation in forensic autopsies using whole slide imaging
PubMed: https://pubmed.ncbi.nlm.nih.gov/41998396/

Paper 2: Integrating AI-Powered Digital Pathology With Case-Based Teaching: A Novel Paradigm for Renal Education in Medical School
PubMed: https://pubmed.ncbi.nlm.nih.gov/41995002/

Paper 3: Application of an open-source AI tool for quantitative quality control in whole slide images of prostate needle core biopsies - a retrospective study
PubMed: https://pubmed.ncbi.nlm.nih.gov/41994924/

Paper 4: Deep-learning-based breast cancer stage prediction from H&E-stained whole-slide images in resource-constrained settings
PubMed: https://pubmed.ncbi.nlm.nih.gov/41993946/

Support the show
Get the "Digital Pathology 101" FREE E-book and join us!

Send us Fan Mail
Paper Discussed in this Episode:
Deep-learning-based breast cancer stage prediction from H&E-stained whole-slide images in resource-constrained settings. Bedőházi Z, Biricz A, Kilim O, et al. Journal of Pathology Informatics 21 (2026) 100644.
Episode Summary:
Welcome back, Trailblazers! In this Journal Club deep dive of the Digital Pathology Podcast, we flip the core assumption of microscopic precision on its head. Can an AI accurately predict pathological breast cancer stages (pTNM I-III) from a blurry, high-altitude 2.5x magnification snapshot? We explore a 2026 study that strips away standard high-resolution data to build a highly efficient, resource-aware AI diagnostic tool for clinics lacking supercomputers. We unpack the math, the models, and a haunting revelation about what primary tumors can tell us about distant metastasis.
In This Episode, We Cover:
• The Compute Bottleneck: Why the digital pathology AI revolution is leaving resource-constrained clinics behind, and how dropping from the standard 40x to 2.5x magnification slashes image patch extraction by 256 times, bypassing massive hardware and server requirements.
• The "Airplane View": How the AI compensates for the loss of microscopic cellular details (like mitosis or cellular atypia) by relying on macroscopic features, identifying disease through overall tumor growth patterns and broad architectural disruption.
• Vision Transformers & "Puzzle Bags": Why the UNI foundation model—a vision transformer fine-tuned on the BRACS dataset—outperforms older convolutional networks (like ResNet-50) by mapping long-range spatial dependencies across the entire image patch simultaneously. Plus, how Multiple Instance Learning (MIL) acts as a targeted "puzzle bag," mathematically weighting critical cancer data and ignoring irrelevant background noise.
• The Real-World Stress Test: The model's solid performance on the internal Semmelweis dataset versus the massive external Nightingale cohort, where unsupervised data cleaning with t-SNE and DBSCAN clustering automatically deleted garbage data. We also discuss the AI's struggle with the TCGA-BRCA dataset due to severe domain shift from heterogeneous tissue preparation, specifically the structural tissue damage caused by frozen sections.
• The "Messy Middle" and Clinical Triage: The model's tendency to struggle with Stage II breast cancer and the critical clinical danger of under-staging advanced Stage III cancers. We discuss why this WSI-only baseline isn't replacing human pathologists, but rather serves as an automated "sorting hat" for incomplete medical records or a highly tunable "smoke detector" to route suspicious slides for immediate manual review.
Key Takeaway:
The AI successfully predicted overall cancer stage—which inherently includes distant lymph node metastasis—by looking only at the primary tumor's architectural disruption, without ever evaluating a single lymph node slide. This proves that vital systemic biological secrets are hiding in plain sight in the macroscopic view of standard H&E slides, offering a phenomenal proof-of-concept for global health equity in resource-constrained settings
Support the show
Get the "Digital Pathology 101" FREE E-book and join us!

Send us Fan Mail
Paper Discussed in this Episode:
Integrating AI-Powered Digital Pathology With Case-Based Teaching: A Novel Paradigm for Renal Education in Medical School. Zhou H, Cui L. Clin Teach 2026; 23(3):e70421. doi: 10.1111/tct.70421.
Episode Summary: In this journal club episode tailored for healthcare trailblazers, we explore a massive paradigm shift in medical education. We examine a 2026 perspective article that uses the notoriously complex field of renal pathology as a stress test for a brand-new teaching model. Moving away from dark lecture halls and static, perfect images, we discuss what happens when artificial intelligence is actively combined with flipped classrooms, fundamentally redefining what it means to be a competent physician in the digital age.
In This Episode, We Cover:
• The "Bottleneck" of Renal Pathology: Why the kidney is the ultimate teaching hurdle. Students must translate the dense, flattened 2D reality of an H&E stain into an understanding of a patient's complex systemic autoimmune response.
• The Danger of the "Curated Reality": Why traditional teaching methods that rely on textbook-perfect, heavily curated slides create "brittle" mental models. When students finally encounter messy, real-world biopsies with overlapping, ambiguous pathologies, the traditional educational foundation falls apart.
• The "Spell Checker" for Histopathology: How collaborative AI elevates Whole Slide Imaging (WSI) beyond just high-resolution screens. The AI acts as a concurrent guide, using pixel-level pattern recognition to highlight regions of interest simultaneously and simulate the complex reasoning process of an expert pathologist.
• The Case-Based Flipped Classroom (CBFC): The pedagogical engine that anchors these AI tools in clinical reality. Instead of passive lectures, students are handed the "detective's case file" beforehand to actively interrogate annotated slides, synthesizing diverse data streams to defend diagnoses in collaborative groups.
• Redefining Medical Competence (The "Clinical Editor"): Why the new bottleneck in medical education isn't memorization—it's critical appraisal. We discuss the necessity of teaching "digital literacy," training students to skeptically manage AI, recognize its blind spots (like confusing a physical tissue fold for an abnormality), and actively audit the algorithm against the messy human reality of the patient.
• The Impending Culture Collision: A look at the fascinating future where freshly minted, AI-native residents enter a legacy clinical workforce still transitioning away from physical glass slides, potentially reversing traditional medical hierarchies in the hospital.
Key Takeaway: The goal of modern medical education is no longer just memorizing histological patterns, as that heavy lifting is being outsourced to algorithms. By fusing AI-powered digital pathology with the necessary friction of case-based learning, we are training a new generation of diagnosticians to view AI not as a crutch, but as a powerful collaborative tool that must be thoughtfully scrutinized and audited for safe patient care
Support the show
Get the "Digital Pathology 101" FREE E-book and join us!

Send us Fan Mail
Paper Discussed in this Episode: Advancements in bone marrow biopsy: the role of omics and artificial intelligence in hematologic diagnostics. Maryam Alwahaibi and Nasar Alwahaibi. Front. Med. 2026; 13:1772478.
Episode Summary: In this journal club deep dive, we explore a paradigm shift in hematopathology, moving from 19th-century visual assessments to the cutting edge of precision medicine. We examine a 2026 review that unpacks how combining artificial intelligence with multi-omics technologies is transforming the traditional bone marrow biopsy from a static, subjective snapshot into a live, interactive, predictive 3D map. We ask: What happens when deep learning can predict underlying genetic mutations just by analyzing the visual shape and texture of a cell?.
In This Episode, We Cover:
The Breaking Point of Traditional Diagnostics: Why the 150-year-old gold standard of H&E staining and human visual assessment is hitting a biological and operational wall, plagued by subjectivity, high variability, and observer fatigue.
The Multi-Omics Multiverse: Moving beyond standard genomics to unpack the complex biological machinery of the marrow, including:
Epigenomics: The biological "switches," like DNA methylation, that control cell fate and can kick off malignant transformation without altering the underlying DNA sequence.
Lipidomics: How cellular fats form specialized signaling rafts that actively remodel the marrow's communication network.
Microbiomics (The Gut-Marrow Axis): How systemic inflammation driven by gut dysbiosis acts like a massive "traffic jam" that indirectly disrupts local bone marrow homeostasis and blood cell production.
AI as the Ultimate Analytical Partner: How artificial intelligence serves as a bridge between physical tissue morphology and high-dimensional molecular data. We discuss AI tools like MarrowQuant for objective cellularity mapping and the Continuous Index of Fibrosis (CIF) that replaces clunky human guesswork with a granular, predictive metric.
Predicting Genotype from Phenotype: The revolutionary capability of deep learning models to predict underlying genetic mutations (like TET2 or del 5q MDS) purely from the subvisual, spatial arrangement and shape of cells on a standard slide.
Roadblocks and Solutions: Why this technology isn't universally adopted yet. We break down the "black box" problem of AI, the brittleness of algorithms in different clinical settings, and how innovations like Federated Learning and Explainable AI (using heat maps) are overcoming these hurdles.
Key Takeaway: The integration of AI and multi-omics is redefining our understanding of bone marrow diseases. By uncovering invisible molecular machinery and objectively translating it through transparent algorithms, we are moving away from subjective human bottlenecks toward a highly personalized, predictive model of hematologic care.

Support the show
Get the "Digital Pathology 101" FREE E-book and join us!

Send us Fan Mail
Paper Discussed in this Episode: Artificial intelligence in clinical oncology: Multimodal integration and translational development. Ruichong Lin, Zhenhui Zhao, Zhonghai Liu, Jin Kang, Kang Zhang, Xiaoying Huang, Yunfang Yu. Cancer Letters 2026; Volume 649, 218493.
Episode Summary: In this journal club deep dive, we explore how cutting-edge AI is fundamentally rewriting the rules of cancer diagnostics. We examine a comprehensive 2026 review on clinical oncology that highlights the shift from narrow, single-modality algorithms to highly sophisticated multimodal AI. We discuss how machines are learning to cross-reference patient charts, genomic data, and medical imaging simultaneously to achieve unprecedented feats—like accurately predicting tumor mutations without ever performing a physical biopsy. Plus, we explore the controversial but necessary world of "computational hallucinations" or synthetic data, which is currently being used to solve diagnostic blind spots.
In This Episode, We Cover:
• The Fragmentation Bottleneck: Why keeping radiology, pathology, genomics, and clinical history in isolated silos limits our ability to treat the whole patient, and why single-modality AI suffers from severe diagnostic "tunnel vision".
• Cross-Modal Attention & Non-Invasive Biopsies: How models like LUCID essentially mimic the deductive reasoning of a multidisciplinary tumor board. By utilizing cross-modal attention mechanisms, LUCID dynamically shifts focus between CT scans, routine labs, and text-based clinical charts to predict EGFR gene mutations in lung cancer entirely non-invasively.
• Graph Neural Networks (GNNs) & Tumor Social Networks: A look at the NePSTA framework, which uses GNNs and spatial transcriptomics to treat the tumor microenvironment like a mathematical topology. By mapping the "social network" of cells, it can rapidly molecularly subtype notoriously ambiguous central nervous system (CNS) tumors in minutes.
• Computational Hallucinations: Introducing MINIM, a generative AI foundation model that creates statistically valid, photorealistic synthetic medical images (like optical CT or chest X-rays) for rare diseases based on textual descriptions. We discuss how intentionally generating these synthesized images solves the critical "data scarcity" problem and directly improves real-world diagnostic accuracy.
• The Reality Check - Distribution Shifts: The dangerous logistical reason why an AI model boasting near-perfect accuracy at a massive urban academic center might fail completely in a rural clinic due to differing scanner calibrations and population demographics. We emphasize why the field must transition away from retrospective "vanity metrics" and toward clinically trustworthy prospective validation.
• The Virtual Cell Paradigm: A staggering look into the near future where AI constructs completely accurate, computationally interactive digital twins of a patient's cancer. This framework allows doctors to test different drug regimens and simulate cellular responses mathematically in silico before ever administering medicine to the actual patient.
Key Takeaway: Multimodal AI proves that cancer diagnostics must go beyond isolated data points. By dynamically synthesizing highly fragmented clinical information and utilizing synthetic imaging to overcome rare disease data scarcity, AI is pushing oncology into an era of robust, individualized molecular phenotyping. Ultimately, these innovations are replacing risky, invasive testing with prec
Support the show
Get the "Digital Pathology 101" FREE E-book and join us!